Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Net Cash Flow (2021 - 2025)

PAVmed (PAVM) has 5 years of Net Cash Flow data on record, last reported at -$901000.0 in Q3 2025.

  • For Q3 2025, Net Cash Flow changed N/A year-over-year to -$901000.0; the TTM value through Sep 2025 reached $2.3 million, changed N/A, while the annual FY2024 figure was -$18.5 million, 7.98% up from the prior year.
  • Net Cash Flow reached -$901000.0 in Q3 2025 per PAVM's latest filing, down from $1.3 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $39.9 million in Q4 2021 and bottomed at -$17.0 million in Q4 2022.
  • Average Net Cash Flow over 5 years is $585277.8, with a median of -$469000.0 recorded in 2024.
  • Peak YoY movement for Net Cash Flow: crashed 3012.74% in 2023, then surged 3624.32% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at $39.9 million in 2021, then crashed by 142.69% to -$17.0 million in 2022, then skyrocketed by 60.28% to -$6.8 million in 2023, then soared by 105.53% to $374000.0 in 2024, then crashed by 340.91% to -$901000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were -$901000.0 in Q3 2025, $1.3 million in Q2 2025, and $1.5 million in Q1 2025.